Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Taspase 1 Inhibitors

Taspase 1 Inhibitors, as a chemical class, represent a diverse group of compounds primarily identified for their ability to indirectly affect the activity of Taspase 1, a threonine endopeptidase known for its crucial role in cleaving specific proteins, including those involved in transcriptional regulation and cell cycle progression. These inhibitors operate through various mechanisms, targeting different pathways and processes within the cell that, in turn, influence Taspase 1's functionality. The inhibitors in this class are not unified by a single chemical structure or mechanism but are rather categorized based on their indirect impact on the pathways that modulate Taspase 1 activity. This includes proteasome inhibitors, kinase inhibitors, and various other molecules that interfere with proteolytic activities and signaling pathways within the cell. For instance, proteasome inhibitors like Bortezomib and MG-132 exert their effects by altering the protein degradation pathways, which may affect the substrates and regulatory proteins associated with Taspase 1. This alteration can influence Taspase 1's role in various cellular processes, including those related to the cell cycle and apoptosis.

This class encompasses inhibitors that target key signaling pathways such as the MAPK/ERK, PI3K/Akt, and JNK pathways, all of which are integral to cellular processes like proliferation, survival, differentiation, and stress response. By modulating these pathways, compounds like U0126, LY294002, and SP600125 indirectly affect the regulatory environment of Taspase 1. The indirect nature of these inhibitors highlights the complex interplay within cellular systems, where altering one component can ripple through multiple processes, impacting enzymes like Taspase 1. Additionally, inhibitors targeting cysteine proteases (e.g., E-64) and thiol proteases (e.g., Leupeptin) contribute to this class by modulating the proteolytic environment, potentially affecting Taspase 1's activity and its related pathways. The diverse chemical structures and modes of action within this class reflect the intricate nature of cellular regulation and the multifaceted approach required to modulate specific enzymes like Taspase 1.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib, a proteasome inhibitor, may indirectly affect Taspase 1 activity by altering protein degradation pathways, potentially impacting Taspase 1 substrates.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132, also a proteasome inhibitor, could influence Taspase 1 indirectly through the stabilization of proteins involved in cell cycle and apoptosis, which are processes Taspase 1 is involved in.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

E-64, an irreversible cysteine protease inhibitor, might impact Taspase 1 indirectly by affecting protease activities within the same cellular pathways.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$75.00
256
(6)

Z-VAD-FMK, a pan-caspase inhibitor, could indirectly modulate Taspase 1 activity through its broad inhibition of caspases, proteins related to cell death and proliferation.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$62.00
$87.00
4
(1)

VX-680 (Tozasertib), a kinase inhibitor, may indirectly affect Taspase 1 by targeting kinases involved in cell cycle regulation, a process in which Taspase 1 participates.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, may affect Taspase 1 indirectly by modulating stress responses and apoptotic pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, could indirectly influence Taspase 1 by altering cellular growth and metabolism pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, a p38 MAPK inhibitor, might have an indirect effect on Taspase 1 by modulating inflammatory responses and cell differentiation processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, another PI3K inhibitor, could affect Taspase 1 activity indirectly through its role in cell growth and survival pathways.